Santiago Acero-Bedoya, MS, BS

Santiago Acero-Bedoya, MS, BS

PhD Candidate
University of Chicago
Chicago, Illinois

Abstract 2100. Dendritic cell-intrinsic PTPN22 negatively regulates anti-tumor immunity. 

What are your long-term career objectives? 

My ultimate is to become a leader in the field of tumor immunology as an independent researcher at a top tier research institution. Moreover, I am equally dedicated to training the next generation of scientist with an emphasis on those from underrepresented backgrounds. 

Please share information about how the COVID-19 pandemic has impacted your research over the last two years. 

The COVID-19 pandemic posed a significant barrier in my graduate studies and my thesis work. Specifically, due to the pandemic, I had to cancel and postpone my laboratory rotations, ultimately pushing my ability to join my thesis lab to the second half of my second year. The pandemic has also placed additional burden and stress on livelihood outside of school, which I consider critical to my success in the lab.